Carson Wealth (CWM LLC)
STLN

Carson Wealth (CWM LLC)’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.12K Buy
1,992
+1,989
+66,300% +$6.1K ﹤0.01% 4957
2025
Q4 		$0 Sell
3
-106
-97% -$393 ﹤0.01% 5642
2025
Q3 		$0 Buy
+109
New +$373 ﹤0.01% 5551

Other funds holding STLN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Carson Wealth (CWM LLC)'s STLN Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Starling Oncology Institute, Inc. Common Stock (STLN) stake by 66,300% in Q1 2026, buying an estimated $6.1K and bringing the position to 1,992 shares worth $6.12K. The position accounts for ﹤0.01% of the portfolio, ranked #4957.

Carson Wealth (CWM LLC) first reported a position in STLN in Q3 2025 and has held it in 3 quarters since. 115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.

  • Carson Wealth (CWM LLC) held 1,992 shares of Starling Oncology Institute, Inc. Common Stock worth $6.12K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 1,989 Starling Oncology Institute, Inc. Common Stock shares in Q1 2026, an estimated $6.1K.
  • Starling Oncology Institute, Inc. Common Stock made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4957 holding.
  • Carson Wealth (CWM LLC) first reported a position in Starling Oncology Institute, Inc. Common Stock in Q3 2025 and has held it in 3 quarters since.
  • 115 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.